Saravia Nancy Gore, Weigle Kristen, Navas Claudia, Segura Iris, Valderrama Liliana, Valencia Anais Zully, Escorcia Blanca, McMahon-Pratt Diane
Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia.
Am J Trop Med Hyg. 2002 Jun;66(6):738-44. doi: 10.4269/ajtmh.2002.66.738.
Leishmania Viannia strains from 1,092 patients who acquired dermal leishmaniasis in endemic regions of Colombia were analyzed for expression of species and subgenus specific epitopes. Eight monoclonal antibodies prepared against membranes of the major species of the Viannia subgenus and previously shown to distinguish these species, recognized low molecular mass (< 45kD) membrane components. Thirteen widely but non-uniformly distributed serodemes were identified: one unique to L. panamensis, four unique to L. braziliensis and eight that were common to L. braziliensis and L. guyanensis. Thirty-seven percent of Colombian L. braziliensis strains concomitantly typed by isoenzymes were null, i.e., not recognized by the corresponding species-specific B-16 or B-18 antibodies. No Colombian L. guyanensis strains were recognized by the antibody specific for this species (B-19). In contrast, L. panamensis-specific B-4 and B11 antibodies recognized > 98% of the L. panamensis strains. Null strains of L. braziliensis and L. panamensis were more frequently isolated from mucosal leishmaniasis than strains that expressed species specific epitopes, suggesting that these strains may be more pathogenic.
对来自哥伦比亚流行地区1092例获得性皮肤利什曼病患者的维氏利什曼原虫菌株进行了种属和亚属特异性表位表达分析。针对维氏亚属主要种的膜制备的8种单克隆抗体,先前已证明可区分这些种,它们识别低分子量(<45kD)的膜成分。鉴定出13个广泛但分布不均的血清型:1个是巴拿马利什曼原虫特有的,4个是巴西利什曼原虫特有的,8个是巴西利什曼原虫和圭亚那利什曼原虫共有的。通过同工酶同时分型的哥伦比亚巴西利什曼原虫菌株中有37%为无效型,即不被相应的种特异性B-16或B-18抗体识别。没有哥伦比亚圭亚那利什曼原虫菌株被该种特异性抗体(B-19)识别。相比之下,巴拿马利什曼原虫特异性B-4和B11抗体识别>98%的巴拿马利什曼原虫菌株。巴西利什曼原虫和巴拿马利什曼原虫的无效型菌株比表达种特异性表位的菌株更频繁地从黏膜利什曼病中分离出来,这表明这些菌株可能更具致病性。